Zhang Zeng, Yang Zhihan, Lin Shijia, Jiang Shuaiming, Zhou Xiaolu, Li Jiahe, Lu Wei, Zhang Jiachao
School of Food Science and Engineering, Key Laboratory of Food Nutrition and Functional Food of Hainan Province, Hainan University, Haikou, China.
Department of Health Management, Haikou People's Hospital/Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, Hainan, China.
Gut Microbes. 2025 Dec;17(1):2520407. doi: 10.1080/19490976.2025.2520407. Epub 2025 Jun 14.
The gut microbiome is essential for maintaining host health, influencing gut function and metabolic regulation. While probiotics are widely used to manage gut health, evidence of their specific effects in healthy individuals remains limited. Most studies focus on diseased populations, with little attention to early interventions in individuals without major diseases. In this study, we investigated the effects of probiotics on gut health in participants free from significant health conditions. Fifty-four participants were randomly assigned to receive either a placebo or composite probiotics for 60 d. Shotgun metagenomics revealed that individuals with lower baseline Gut Microbiome Wellness Index 2 (GMWI) exhibited more decisive responses to probiotic intervention, characterized by an increased abundance of beneficial commensal bacteria, including . Probiotic intake significantly improved the function of the gut microbiome, reducing antibiotic resistance genes and virulence factors while enhancing carbohydrate-active enzymes. Notably, promoted the production of palmitoyl serinol, a metabolite associated with improved GMWI and preventive benefits in blood glucose. In a population-based experiment, these findings were validated in a follow-up single-strain probiotic intervention with Zhang. Our study highlights the potential of probiotics as an early intervention strategy for maintaining gut health in individuals without significant health conditions.
肠道微生物群对于维持宿主健康、影响肠道功能和代谢调节至关重要。虽然益生菌被广泛用于管理肠道健康,但其在健康个体中的具体作用证据仍然有限。大多数研究集中在患病群体,很少关注对无重大疾病个体的早期干预。在本研究中,我们调查了益生菌对无明显健康问题参与者肠道健康的影响。54名参与者被随机分配接受安慰剂或复合益生菌,为期60天。鸟枪法宏基因组学显示,基线肠道微生物群健康指数2(GMWI)较低的个体对益生菌干预表现出更明显的反应,其特征是有益共生菌丰度增加,包括 。摄入益生菌显著改善了肠道微生物群的功能,减少了抗生素耐药基因和毒力因子,同时增强了碳水化合物活性酶。值得注意的是, 促进了棕榈酰丝氨醇的产生,棕榈酰丝氨醇是一种与改善GMWI和预防血糖有益作用相关的代谢物。在一项基于人群的实验中,这些发现通过对 张进行的后续单菌株益生菌干预得到了验证。我们的研究强调了益生菌作为一种早期干预策略在维持无明显健康问题个体肠道健康方面的潜力。